← 返回

结合于卷曲螺旋肽-聚合物偶联物的肿瘤标志物 B7-H6 通过激活人 NK 细胞实现靶向治疗

英文原题:Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells.

查看英文原题

Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells.

PubMed 2021/11/02(内容时间) Biomedicines Q2 · IF 4.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

靶向癌症免疫疗法有望恢复免疫监视并清除癌细胞。经卷曲螺旋肽标签修饰的亲水聚合物,可作为通用载体实现此类生物活性蛋白的细胞特异性递送。本文介绍一种基于pHPMA的共聚物制备方法:通过互补卷曲螺旋肽序列VAALEKE(肽E)和VAALKEK(肽K),将具有免疫活性的B7-H6蛋白偶联至共聚物。受体B7-H6被认为是NKp30的结合配体,并已证实表达于多种肿瘤细胞系。B7-H6与NKp30结合可激活NK细胞,并通过Fas配体或颗粒酶介导靶肿瘤细胞凋亡。本研究优化了卷曲螺旋标签B7-H6的表达;等温滴定量热法证实其能够结合活化受体NKp30;分析超速离心表征了所制备嵌合生物聚合物的结合化学计量。此外,该负载卷曲螺旋B7-H6的聚合物偶联物可在体外激活NK细胞,并与卷曲螺旋scFv联合,使其靶向一种模型肿瘤细胞系。该嵌合生物聚合物有望通过激活NK细胞细胞毒活性,成为靶向癌症免疫疗法的前体。

展开英文摘要原文

Targeted cancer immunotherapy is a promising tool for restoring immune surveillance and eradicating cancer cells. Hydrophilic polymers modified with coiled coil peptide tags can be used as universal carriers designed for cell-specific delivery of such biologically active proteins.

Here, we describe the preparation of pHPMA-based copolymer conjugated with immunologically active protein B7-H6 via complementary coiled coil VAALEKE (peptide E) and VAALKEK (peptide K) sequences. Receptor B7-H6 was described as a binding partner of NKp30, and its expression has been proven for various tumor cell lines.

The binding of B7-H6 to NKp30 activates NK cells and results in Fas ligand or granzyme-mediated apoptosis of target tumor cells. In this work, we optimized the expression of coiled coil tagged B7-H6, its ability to bind activating receptor NKp30 has been confirmed by isothermal titration calorimetry, and the binding stoichiometry of prepared chimeric biopolymer has been characterized by analytical ultracentrifugation.

Furthermore, this coiled coil B7-H6-loaded polymer conjugate activates NK cells in vitro and, in combination with coiled coil scFv, enables their targeting towards a model tumor cell line. Prepared chimeric biopolymer represents a promising precursor for targeted cancer immunotherapy by activating the cytotoxic activity of natural killer cells.

论文信息

作者
Kalousková B、Skořepa O、Cmunt D、Abreu C、Krejčová K、Bláha J、Sieglová I、Král V
单位
Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030, 12840 Prague, Czech Republic.Czechia
期刊
Biomedicines2021 Nov 2
原文标识
PubMed 34829829 · DOI 10.3390/biomedicines9111597